Codes / ICD10CM / F13.282

F13.282 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Sedative, Hypnotic, or Anxiolytic Dependence with Sedative, Hypnotic or Anxiolytic-Induced Sleep Disorder

Summary

This condition involves a physical and psychological dependence on sedative, hypnotic, or anxiolytic substances, accompanied by a sleep disorder induced by these drugs. These medications are typically prescribed for anxiety or sleep disorders but can lead to dependence with prolonged or improper use. The dependence is characterized by a persistent pattern of use that results in clinically significant impairment or distress, while the induced sleep disorder may manifest as insomnia, hypersomnia, or other sleep-related disturbances.

Causes

Long-term use or misuse of sedative, hypnotic, or anxiolytic medications can lead to dependence. Factors include using higher doses than prescribed, using the medication for longer than intended, or using them recreationally. The induced sleep disorder may arise from withdrawal, tolerance, or direct pharmacological effects of the substances, disrupting normal sleep patterns.

Risk Factors

  • A history of substance abuse or addiction.
  • Co-occurring mental health disorders, such as anxiety or depression.
  • Chronic stress or trauma.
  • Easy access to sedative, hypnotic, or anxiolytic medications.
  • Family history of substance use disorders.
  • Genetic predispositions to addiction.

Symptoms

  • Cravings for the substance.
  • Withdrawal symptoms when not using the drug (e.g., anxiety, insomnia, tremors).
  • Increased tolerance to the medication.
  • Neglect of personal or professional responsibilities.
  • Continued use despite knowing the harms.
  • Sleep disturbances, such as difficulty falling asleep, staying asleep, or excessive sleepiness.

Diagnosis

Diagnosis typically involves a comprehensive evaluation by a healthcare provider, including a detailed substance use history, mental health assessment, and possibly urine or blood tests to detect drug use. The provider will assess the pattern of dependence and the specific sleep disorder symptoms to confirm the diagnosis.

Treatment Options

Treatment may include detoxification to manage withdrawal, behavioral therapies to address dependence, and medications to treat the induced sleep disorder. Supportive care, such as counseling or support groups, can also help address underlying issues and prevent relapse.

Prognosis and Follow-Up

Prognosis depends on the severity of dependence, the individual's commitment to treatment, and the presence of co-occurring conditions. Regular follow-up is important to monitor progress, adjust treatment, and address any ongoing sleep or substance use issues.

Complications

  • Worsening of sleep disorders.
  • Increased risk of overdose or other substance-related harm.
  • Impaired daily functioning.
  • Co-occurring mental health conditions.
  • Social or occupational difficulties.

Lifestyle & Prevention

  • Use sedative, hypnotic, or anxiolytic medications only as prescribed and for the shortest duration necessary.
  • Avoid mixing these substances with alcohol or other drugs.
  • Seek alternative therapies for anxiety or sleep issues when possible.
  • Maintain a consistent sleep schedule and healthy sleep hygiene.
  • Engage in stress-reduction techniques, such as exercise or mindfulness.

When to Seek Professional Help

Seek help if you experience persistent cravings, withdrawal symptoms, or difficulty controlling use of these substances. Also, consult a healthcare provider if sleep disturbances persist or worsen, as they may indicate an induced disorder requiring treatment.

Tips for Medical Coders

When coding for F13.282, ensure documentation clearly specifies both the sedative, hypnotic, or anxiolytic dependence and the presence of a sedative, hypnotic, or anxiolytic-induced sleep disorder. The sleep disorder must be directly linked to the substance use, and the dependence should be clinically significant. Verify that the diagnosis aligns with the criteria for both dependence and the induced disorder to support accurate coding.

Book a walkthrough

F13.282 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.